Moreover, PLA2G7 impairment reduced aldehyde dehydrogenase activity, considered as a marker of prostate cancer stem cells as well as tumor- and metastasis-initiating prostate cancer cells [23-25] supporting the possibility that PLA2G7 expression may have prognostic significance. This evidence concerns the gene PLA2G7 and prostate carcinoma.